| CST I (L. crispatus) | CST III (L. iners) | CST IV (Lactobacillus sp. deplete, high diversity) |
---|---|---|---|
Analysis 1 | |||
 Pre-treatment, n = 103 | 45/103 (44) | 37/103 (36) | 21/103 (20) |
 Control, n = 39 | 22/39 (56) | 16/39 (41) | 1/39 (3) |
 p value | 0.1920 | 0.6978 | 0.0081 |
Analysis 2 | |||
 Pre-treatment, n = 103 | 45/103 (44) | 37/103 (36) | 21/103 (20) |
 Post-treatment, n = 103 | 40/103 (39) | 44/103 (43) | 19/103 (18) |
 p value | 0.5715 | 0.3922 | 0.8604 |
Analysis 3 | |||
 Post-treatment, n = 103 | 40/103 (39) | 44/103 (43) | 19/103 (18) |
 Control, n = 39 | 22/39 (56) | 16/39 (41) | 1/39 (3) |
 p value | 0.0873 | 1.000 | 0.0142 |
Sub-group analysis 3A | |||
 Post-treatment, normal cytology, n = 81 | 32/81 (40) | 35/81 (43) | 14/81 (17) |
 Control, n = 39 | 22/39 (56) | 16/39 (41) | 1/39 (3) |
 p value | 0.1166 | 0.8463 | 0.0354 |
Sub-group analysis 3B | |||
 Post-treatment, normal cytology, HPV-negative, n = 70 | 27/70 (38) | 30/70 (43) | 13/70 (19) |
 Control, HPV negative, n = 23 | 12/23 (52) | 10/23 (44) | 1/23 (4) |
 p value | 0.3309 | 1.0000 | 0.1758 |